Sex hormone modulation of serotonin-induced coronary vasodilation in isolated heart

Brazilian Journal of Medical and Biological Research

Volumn 34, Issue 7, 2001, Pages 949-958

  Moyses M R ^a   Barker, L A ^b   Cabral, A M ^a  

^a FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Coronary circulation; Endothelial function; Estradiol; Serotonin; Smooth muscle

Indexed keywords

ESTRADIOL; PROGESTERONE; SEROTONIN; SEX HORMONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CASTRATION; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DILATATION; CORONARY ARTERY DISEASE; DOSE RESPONSE; FEMALE; HORMONAL REGULATION; ISOLATED HEART; MALE; NONHUMAN; PATHOPHYSIOLOGY; RAT; SEX DIFFERENCE;

ANIMALIA;

EID: 0034904083     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2001000700014     Document Type: Article

References (40)

1. Luscher TF & Vanhoutte PM (1990) The Endothelium: Modulator of Cardiovascular Function. CRC Press, Boca Raton.
2. Crofton JT, Ratliff DL, Brooks DP & Share L (1986). The metabolic clearance rate of and presser responses to vasopressin in male and female rats. Endocrinology, 118: 1777-1781.
3. Freedman RR, Sabharwal SC & Desai N (1987) Sex differences in peripheral vascular adrenergic receptors. Circulation Research, 61: 581-585.
4. 2+ currents in A7r5 vascular smooth muscle cell line. American Journal of Physiology, 266: C975-C980.
5. Kannel WB, Hjortland MC, McNamara PM & Gordon T (1976). Menopause and risk of cardiovascular disease: The Framingham Study. Annals of Internal Medicine, 85: 447-452.
6. Rowland NE & Fregly MJ (1992) Role of gonadal hormones in hypertension in the Dahl salt-sensitive rat. Clinical and Experimental Hypertension, 14: 367-375.
7. Stampfer MJ, Colditz GA, Willett WC, Manson JAE, Rosner B, Speizer FE & Hennekens CH (1991). Postmenopausa estrogen therapy and cardiovascular disease: Ten year follow-up from the Nurses' Health Study. New England Journal of Medicine, 325: 756-762.
8. Grady D, Rubin SM & Petiti DB (1992). Hormone therapy to prevent disease and prolong life in postmenopausal women. Annals of Internal Medicine, 117: 1016-1037.
9. Walsh BW, Schiff I, Rosner B, Greenberg L, Ravnikar V & Sacks FM (1991). Effects of postmenopausal oestrogen replacement on the concentrations and metabolism of plasma lipoprotems. New England Journal of Medicine, 325: 1196-1204.
10. Bush TL, Barret-Connor E, Cowan LD, Criqui MH, Wallace RB, Suchindran CM, Tyroler HA & Rifkind BM (1987) Cardiovascular mortality and noncontraceptive use of estrogen in women: Results from the Lipid Research Clinics Program Follow Up Study.Circulation, 75: 1102-1109.
11. Barret-Connor E & Bush TL (1991), Estrogen and coronary heart disease in women. Journal of the American Medical Association, 265: 1861-1867.
12. Adams MR, Clarkson TB, Kaplan JR & Kontnik DR (1990). Ovarian secretions and atherosclerosis. In: Naftolin F, Gutmann JN, DeCherney AH & Sarrel PM (Editors), Ovarian Secretions and Cardiovascular and Neurological Function. Raven Press, New York, 151-159.
13. Gisclard V, Miller VM & Vanhoutte PM (1988) Effect of 17ß-estradiol on endothelium-dependent responses in the rabbit. Journal of Pharmacology and Experimental Therapeutics, 244: 19-22.
14. Hayashi T, Fukuto JM, Ignarro LJ & Chaudhuri G (1992). Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: implications for atherosclerosis. Proceedings of the National Academy of Sciences, USA, 89: 11259-11263.
15. Van-Buren GA, Yang D & Clark KE (1992). Estrogen-induced uterine vasodilatation is antagonized by L-nitroarginine methyl ester, an inhibitor of nitric oxide synthesis. American Journal of Obstetrics and Gynecology, 167: 828-833.
16. Collins P. Rosano GMC, Jiang C, Lindsay D, Sarrel PM & Poole-Wilson PA (1993). Cardiovascular protection by oestrogen -a calcium antagonist effect? Lancet, 341: 1264-1265.
17. Magness R & Rosenfeld CR (1989) Local and systemic estradiol-17ß: effects on uterine and systemic vasodilation. American Journal of Physiology, 256: E536-E542.
18. Jiang C, Sarrel PM, Lindsay DC, Poole-Wilson PA & Collins P (1991). Endothelium-independent relaxation of rabbit coronary artery by 17ß-oestradiol in vitro. British Journal of Pharmacology, 104: 1033-1037.
19. De Clerck F & Reneman RS (1985). Platelet-derived serotonin and abnormal tissue perfusion. In: De Clerck F & Vanhoutte PM (Editors), Serotonin and the Cardiovascular System. Raven Press, New York, 155-163.
20. Golino P, Piscione F, Willerson JT, Cappelli-Bigazzi M, Focaccio A, Villari B, Irdolfi C, Russolillo E, Condorelli M & Chiariello M (1991). Divergent effects of serotonin on coronary artery dimensions and blood flow in patients with coronary atherosclerosis and control patients. New England Journal of Medicine, 324: 641-648.
21. Riedel M, Oeltermann A, Mügge A, Creutzig A, Rafflenbeul W & Lichtlen P (1995). Vascular responses to 17ß-oestradiol in postmenopausal women. European Journal of Clinical Investigation, 25: 44-47.
22. Farhat MY, Abi-Younes S & Ramwell PM (1996). Nongenomic effects of estrogen and the vessel wall. Biochemical Pharmacology, 51: 571-576.
23. Cheng DY & Gruetter CA (1992). Chronic estrogen alters contractile responsiveness to angiotensm II and norepinephrine in female rat aorta. European Journal of Pharmacology, 215: 171-176.
24. Gilligan DM, Badar DM, Panza JÁ, Quyyumi AA & Cannon RO (1994). Acute vascular effects of estrogen in postmenopausal women. Circulation, 90: 786-791.
25. Taddei S, Virdis A, Ghiadoni L, Mattel P, Sudano I, Bernini G, Pinto S & Salvetti A (1996). Menopause is associated with endothelial dysfunction in women. Hypertension, 28: 576-582.
26. Rosselli M, Imthurn B, Keller PJ, Jackson EK & Dubey RK (1995). Circulating nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17ß-estradiol and norethisterone acetate. Hypertension, 25: 848-853.
27. Rosano GMC, Sarrel PM, Poole-Wilson PA & Collins P (1993). Beneficial effect of oestrogen on exercise-induced myocardial ischaemia in women with coronary artery disease. Lancet, 342: 133-136.
28. Colucci WS, Gimbrone MA, McLaughlin MK, Halpern W & Alexander RW (1982). Increased vascular catecholamine sensitivity and alpha 1-adrenergic receptor affinity in female and estrogen treated male rats. Circulation Research, 50: 805-811.
29. Hamlet MA, Rorie DK & Tyce GM (1980). Effects of estradiol on release and disposition on norepinephnne from nerve endings. American Journal of Physiology, 239: H450-H456.
30. Rorie DK & Muldoon SM (1979). Increased reactivity of isolated rabbit saphenous vein after treatment with estrogen and progesterone. Blood Vessels, 16: 252-258.
31. Dzau VJ (1988). Circulating versus local renin-angiotensin system in cardiovascular homeostasis. Circulation, 77 (Suppl 1): 4-13.
32. Oelskers WKH (1996). Effects of estrogens and progestogens on the renin-aldosterone system and blood pressure. Steroids, 61: 166-171.
33. Houston DS & Vanhoutte PM (1988). Comparison of serotonergic receptor subtypes on the smooth muscle and endothelium of the canine coronary artery. Journal of Pharmacology and Experimental Therapeutics, 244: 1-10.
34. Kelm M & Schrader J (1990). Control of coronary vascular tone by nitric oxide. Circulation Research, 66: 1561-1575.
35. Colburn P & Buonassisi V (1978). Estrogen binding sites in endothelial cell cultures. Science, 201: 817-819.
36. Horwitz KB & Horwitz CD (1982). Canine vascular tissue are targets for androgens, estrogens, progestins and glucocorticoids. Journal of Clinical Investigation, 69: 750-758.
37. Losordo DW, Kearney M, Kim EA, Jekanowski J & Isner JM (1994). Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries in premenopausal women. Circulation, 89: 1501-1510.
38. Hayashi T, Yamada K, Esaki T, Kuzuya M, Satake S, Ishikawa T, Hidaka H & Iguchi A (1995). Estrogen increases endothelial nitric oxide by a receptor mediated system. Biochemical and Biophysical Research Communications, 214: 847-855.
39. Schray-Utz B, Zeither AM & Busse R (1993). Expression of constitutive NO synthase in cultured endothelial cells is enhanced by 17ß-estradiol. Circulation, 88 (Suppl 1): 1-80 (Abstract).
40. Weiner CP, Lizasoain I, Baylis AS, Knowles RG, Charles IG & Moncada S (1994). Induction of calcium-dependent nitric oxide syntheses by sex hormones. Proceedings of the National Academy of Sciences, USA, 91: 5212-5216.